Felipe Navas, M.D.
NPI 1508889403 · Ophthalmology Physician · San Antonio, TX
Enrolled with Medicare as Practitioner - Ophthalmology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1508889403
- Entity type
- Individual
- Primary specialty
- Ophthalmology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- No
- License
- M4392 (TX)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
19 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
1,712 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Imaging of Retina92134 | 521 | $40 |
| Established Patient Complete Exam of Visual System92014 | 501 | $125 |
| Injection of Drug Into Eye67028 | 296 | $112 |
| Compounded Drug, Not Otherwise ClassifiedJ7999 | 96 | $84 |
| New Patient Office Or Other Outpatient Visit With Moderate Level of Medical Decision Making, If Using Time, 45 Minutes Or More99204 | 87 | $168 |
| Extended Exam of the Back Part of the Eye With Retinal Drawing92201 | 86 | $25 |
| Photography of the Retina |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 10 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Afliberceptbrand: Eylea | 566 | 141 |
| Faricimab-Svoabrand: Vabysmo | 78 | 23 |
| Prednisolone Acetate | 41 | 13 |
| Dorzolamide Hcl/Timolol Maleatbrand: Dorzolamide-Timolol | 30 | 18 |
| Afliberceptbrand: Eylea Hd | 23 | — |
| Ketorolac Tromethamine | 21 | — |
| Nepafenacbrand: Ilevro | 21 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$1,360 across 23 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-07-25
- Last updated
- 2017-04-25
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.